irblog.prnewswire.com

Microbion Corporation Announces Results from Randomized, Double Blind, Placebo-Controlled Phase 1b Trial of Pravibismane (MBN-101) for Treatment of Moderate to Severe Chronic ...

BOZEMAN, Mont. and VANCOUVER, British Columbia, Oct. 28, 2019 /PRNewswire/ -- Microbion Corporation of Bozeman, MT, and Microbion Pharma Corp. of Vancouver, BC ("Microbion") today announced results ...
irblog.prnewswire.com

Microbion Awarded up to $17.1 Million from CARB-X and the Cystic Fibrosis Foundation to Develop Inhaled Antimicrobial for Chronic Respiratory Infections in CF

BOZEMAN, Mont., May 28, 2020 /PRNewswire/ -- Microbion Corporation of Bozeman, Montana today announced it has been awarded up to US$17.1 million from CARB-X and the Cystic Fibrosis Foundation to ...
Yahoo Finance

Microbion Granted Qualified Infectious Disease Product (QIDP) Designation for Adjunctive Treatment of Moderate and Severe Diabetic Foot Infections From U.S. FDA for MBN-101

BOZEMAN, MT and VANCOUVER, BC--(Marketwired - May 26, 2016) - Microbion Corporation ("Microbion") of Bozeman, MT, USA and Microbion Pharma Corp. of Vancouver, BC, Canada, today announced that the U.S.
Mena FN

Microbion Announces Positive Topline Results From Phase 2 Study Of Topical Pravibismane For Moderately Infected Diabetic Foot Ulcers

pravibismane High patient compliance observed with at-home self-treatment Data demonstrated a numerical treatment benefit across multiple efficacy measures, including full wound closure, despite study ...
WWLP

Microbion Corporation Announces Granting of a US Patent for the Use of Topical Pravibismane for Diabetic Foot Ulcer Infections

BOZEMAN, Mont., and VANCOUVER, BC, March 15, 2022 /PRNewswire/ - Microbion Corporation today announced that the US Patent and Trademark Office (USPTO) issued United States Patent No. 11,207,288 to ...
Yahoo Finance

Microbion and Haisco Announce Equity Investment and Development & Commercialization Agreement for MBN-101 in China and Related Territories

BOZEMAN, MT and VANCOUVER, BC--(Marketwired - March 01, 2016) - Microbion Corporation ("Microbion") of Bozeman, MT, USA and Microbion Pharma Corp. of Vancouver, BC, Canada, today announced that ...
Yahoo Finance

Microbion Corporation Announces FDA Has Granted Fast Track Designation to MBN-101 for the Adjunctive Treatment of Moderate and Severe Diabetic Foot Ulcer Infections

BOZEMAN, MT, and VANCOUVER, BC--(Marketwired - August 04, 2016) - Microbion Corporation ("Microbion") of Bozeman, MT, USA and Microbion Pharma Corp. of Vancouver, BC, Canada, specializing in the ...
Newswire

Microbion Corporation Receives up to $2.1 million in Funding Support from the US Navy in Partnership with CUBRC, Inc. to Advance Topical Pravibismane

Funding will support exploratory phase 2 proof-of-concept study in patients hospitalized for moderate to severe diabetic foot ulcer infection (DFI) "We are pleased to be supported by the US Navy and ...
MarketWatch

(PR) Microbion Announces Positive Topline Results from Phase 2 Study of Topical Pravibismane for Moderately Infected Diabetic Foot Ulcers

-- Study achieves primary endpoint, demonstrating safety and tolerability of 12-week treatment regimen with high-concentration of topical pravibismane -- High patient compliance observed with at-home ...
Yahoo Finance

Microbion and Haisco Announce Equity Investment and Development & Commercialization Agreement for MBN-101 in China and Related Territories

BOZEMAN, MT and VANCOUVER, BC--(Marketwired - March 01, 2016) - Microbion Corporation ("Microbion") of Bozeman, MT, USA and Microbion Pharma Corp. of Vancouver, BC, Canada, today announced that ...